This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

4 Stocks Under $10 Ripping Higher

Idenix Pharmaceuticals

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

Idenix Pharmaceuticals (IDIX) is a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases with operations in the U.S. and Europe. This stock is trading up 3.9% to $9.96 in recent trading.

Today's Range: $9.58-$9.96

52-Week Range: $4.60-$15.25

Volume: 354,000

Three-Month Average Volume: 1.5 million

>>22 Biopharma Stocks With Breakout Potential in 2012

From a technical perspective, IDIX is bouncing notably here right near its 50-day moving average of $9.46 with light volume. This stock recently ran into some heavy resistance at around $11.30, but shares of IDIX are still well within an uptrend that started back in May at $7.36. During that uptrend, shares of IDIX have been making mostly higher lows and higher highs, which is bullish technical price action. The recent pullback for IDIX to its 50-day moving average could be representing a solid buying opportunity.

Traders should now look for long-biased trades as long as IDIX can hold above both its 50-day at $9.46 and its 200-day at $9.10 with strong upside volume flows. I would consider any upside volume day that registers near or above 1.5 million shares as bullish. If those levels hold, then IDIX will have a great chance of re-testing and possibly taking out $11.30.

As of the most recently reported period, IDIX was one of Seth Klarman's Baupost Group holdings.

4 of 5

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG
IDIX $24.50 0.20%
FTEK $2.85 0.00%
QLTI $3.70 0.00%
SWIR $37.32 0.00%
AAPL $130.28 0.00%

Markets

DOW 18,080.14 +21.45 0.12%
S&P 500 2,117.69 +4.76 0.23%
NASDAQ 5,092.0850 +36.0220 0.71%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs